Qiagen to Stick with Small Acquisitions in 2006 as Part of Molecular Dx Growth Plan | GenomeWeb

Qiagen will stick with its strategy of acquiring smaller companies focused on the preanalytical space as it targets continued growth in the molecular diagnostics market, according to CEO Peer Schatz.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.